Survival rates for those diagnosed with typical<unk> , and left untreated is 11.18 years with a standard deviation of 7.8 years. A study reporting good outcomes in a single patient with late onset<unk>  has been performed.
Pantothenate kinase-associated neurodegeneration
Cerebral creatine deficiency
Neuronal ceroid lipofuscinosis
N-Acetylglutamate synthase deficiency
Autoimmune GFAP astrocytopathy
Dopamine beta hydroxylase deficiency
Glycogen storage disease
Lysosomal storage disease